![](../../files/images/goods/17230-88-5.png)
Danazol
CAS No. 17230-88-5
Danazol ( Danocrine; Ladogal; NSC 270916; WIN 17,757 )
Catalog No. M12621 CAS No. 17230-88-5
Danazol is a derivative of the synthetic steroid ethisterone.
Purity : >98%(HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
Size | Price / USD | Stock | Quantity |
50MG | 59 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDanazol
-
NoteResearch use only, not for human use.
-
Brief DescriptionDanazol is a derivative of the synthetic steroid ethisterone.
-
DescriptionDanazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.
-
SynonymsDanocrine; Ladogal; NSC 270916; WIN 17,757
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor; ER; ER; GNRHR
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number17230-88-5
-
Formula Weight337.46
-
Molecular FormulaC22H27NO2
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5
-
Chemical Name(1R,3aS,3bR,10aR,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/ct2.png)
related products
-
ORM-15341
The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.
-
UT-34
UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prostate cancer efficacy. In LNCaP cells, UT-34 (3-10 μM; 24 hours) treatment inhibits the expression of PSA and FKBP5 and growth of LNCaP cells starting from 100 nM with maximum effect observed at 10 μM.
-
LGD-2226
LGD-2226 (LGD2226) is an orally active, selective androgen receptor modulator (SARM) with binding Ki of 1 nM.